Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Anesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
PLoS One. 2022 Sep 2;17(9):e0273697. doi: 10.1371/journal.pone.0273697. eCollection 2022.
Severe acute respiratory infections (SARI) pose a great global burden. The contribution of respiratory viruses to adult SARI is relatively understudied in Asia. We aimed to determine viral aetiology of adult SARI patients in Kuala Lumpur, Malaysia.
The prevalence of 20 common (mainly viral) respiratory pathogens, and MERS-CoV, SARS-CoV and 5 bacterial select agents was investigated from May 2017 to October 2019 in 489 SARI adult patients in Kuala Lumpur, Malaysia, using molecular assays (Luminex NxTAG-RPP kit and qPCR assays). Viral metagenomics analysis was performed on 105 negative samples.
Viral respiratory pathogens were detected by PCR in 279 cases (57.1%), including 10 (2.0%) additional detections by metagenomics analysis. The most detected viruses were rhinovirus/enterovirus (RV/EV) (49.1%) and influenza virus (7.4%). Three melioidosis cases were detected but no SARS-CoV, MERS-CoV or other bacterial select agents. Bacterial/viral co-detections and viral co-detections were found in 44 (9.0%) and 27 (5.5%) cases respectively, mostly involving RV/EV. Independent predictors of critical disease were male gender, chronic lung disease, lack of runny nose and positive blood culture with a significant bacterial pathogen. Asthma and sore throat were associated with increased risk of RV/EV detection, while among RV/EV cases, males and those with neurological disease were at increased risk of critical disease.
Prior to the COVID-19 pandemic, the high prevalence of respiratory viruses in adults with SARI was mainly attributed to RV/EV. Continued surveillance of respiratory virus trends contributes to effective diagnostic, prevention, and treatment strategies.
严重急性呼吸道感染(SARI)给全球带来了巨大负担。亚洲对成人 SARI 中呼吸道病毒的贡献相对研究较少。我们旨在确定马来西亚吉隆坡成人 SARI 患者的病毒病因。
2017 年 5 月至 2019 年 10 月,采用分子检测方法(Luminex NxTAG-RPP 试剂盒和 qPCR 检测)对 489 例马来西亚吉隆坡成人 SARI 患者进行了 20 种常见(主要为病毒)呼吸道病原体和 MERS-CoV、SARS-CoV 以及 5 种细菌选择剂的流行率检测。对 105 份阴性样本进行了病毒宏基因组学分析。
PCR 检测到 279 例(57.1%)患者存在病毒呼吸道病原体,其中 105 例(2.0%)通过宏基因组学分析额外检测到。最常见的病毒为鼻病毒/肠道病毒(RV/EV)(49.1%)和流感病毒(7.4%)。检测到 3 例类鼻疽病例,但未检测到 SARS-CoV、MERS-CoV 或其他细菌选择剂。在 44 例(9.0%)和 27 例(5.5%)患者中分别发现了细菌/病毒共检出和病毒共检出,主要涉及 RV/EV。严重疾病的独立预测因素为男性、慢性肺部疾病、无流鼻涕以及阳性血培养伴显著细菌病原体。哮喘和咽痛与 RV/EV 检出率增加相关,而在 RV/EV 病例中,男性和患有神经系统疾病的患者患严重疾病的风险增加。
在 COVID-19 大流行之前,成人 SARI 中呼吸道病毒的高流行率主要归因于 RV/EV。对呼吸道病毒趋势的持续监测有助于制定有效的诊断、预防和治疗策略。